Applicability of precision medicine approaches to managing hypertension in rural populations

Jacqueline R. Halladay, Kaitlin C. Lenhart, Kimberly Robasky, Wendell Jones, Wayne F. Homan, Doyle M. Cummings, Crystal W. Cené, Alan L. Hinderliter, Cassandra L. Miller, Katrina E. Donahue, Beverly A. Garcia, Thomas C. Keyserling, Alice S. Ammerman, Cam Patterson, Darren A. Dewalt, Larry F. Johnston, Monte Willis, Jonathan C. Schisler

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

As part of the Heart Healthy Lenoir Project, we developed a practice level intervention to improve blood pressure control. The goal of this study was: (i) to determine if single nucleotide polymorphisms (SNPs) that associate with blood pressure variation, identified in large studies, are applicable to blood pressure control in subjects from a rural population; (ii) to measure the association of these SNPs with subjects’ responsiveness to the hypertension intervention; and (iii) to identify other SNPs that may help understand patient-specific responses to an intervention. We used a combination of candidate SNPs and genome-wide analyses to test associations with either baseline systolic blood pressure (SBP) or change in systolic blood pressure one year after the intervention in two genetically defined ancestral groups: African Americans (AA) and Caucasian Americans (CAU). Of the 48 candidate SNPs, 13 SNPs associated with baseline SBP in our study; however, one candidate SNP, rs592582, also associated with a change in SBP after one year. Using our study data, we identified 4 and 15 additional loci that associated with a change in SBP in the AA and CAU groups, respectively. Our analysis of gene-age interactions identified genotypes associated with SBP improvement within different age groups of our populations. Moreover, our integrative analysis identified AQP4-AS1 and PADI2 as genes whose expression levels may contribute to the pleiotropy of complex traits involved in cardiovascular health and blood pressure regulation in response to an intervention targeting hypertension. In conclusion, the identification of SNPs associated with the success of a hypertension treatment intervention suggests that genetic factors in combination with age may contribute to an individual’s success in lowering SBP. If these findings prove to be applicable to other populations, the use of this genetic variation in making patient-specific interventions may help providers with making decisions to improve patient outcomes. Further investigation is required to determine the role of this genetic variance with respect to the management of hypertension such that more precise treatment recommendations may be made in the future as part of personalized medicine.

Original languageEnglish (US)
Article number16
JournalJournal of Personalized Medicine
Volume8
Issue number2
DOIs
StatePublished - Jun 1 2018
Externally publishedYes

Fingerprint

Precision Medicine
Rural Population
Blood Pressure
Hypertension
Single Nucleotide Polymorphism
African Americans
Genetic Engineering

Keywords

  • GWAS
  • Hypertension
  • Precision medicine
  • Rural population
  • SNP-age interaction

ASJC Scopus subject areas

  • Medicine (miscellaneous)

Cite this

Halladay, J. R., Lenhart, K. C., Robasky, K., Jones, W., Homan, W. F., Cummings, D. M., ... Schisler, J. C. (2018). Applicability of precision medicine approaches to managing hypertension in rural populations. Journal of Personalized Medicine, 8(2), [16]. https://doi.org/10.3390/jpm8020016

Applicability of precision medicine approaches to managing hypertension in rural populations. / Halladay, Jacqueline R.; Lenhart, Kaitlin C.; Robasky, Kimberly; Jones, Wendell; Homan, Wayne F.; Cummings, Doyle M.; Cené, Crystal W.; Hinderliter, Alan L.; Miller, Cassandra L.; Donahue, Katrina E.; Garcia, Beverly A.; Keyserling, Thomas C.; Ammerman, Alice S.; Patterson, Cam; Dewalt, Darren A.; Johnston, Larry F.; Willis, Monte; Schisler, Jonathan C.

In: Journal of Personalized Medicine, Vol. 8, No. 2, 16, 01.06.2018.

Research output: Contribution to journalArticle

Halladay, JR, Lenhart, KC, Robasky, K, Jones, W, Homan, WF, Cummings, DM, Cené, CW, Hinderliter, AL, Miller, CL, Donahue, KE, Garcia, BA, Keyserling, TC, Ammerman, AS, Patterson, C, Dewalt, DA, Johnston, LF, Willis, M & Schisler, JC 2018, 'Applicability of precision medicine approaches to managing hypertension in rural populations', Journal of Personalized Medicine, vol. 8, no. 2, 16. https://doi.org/10.3390/jpm8020016
Halladay, Jacqueline R. ; Lenhart, Kaitlin C. ; Robasky, Kimberly ; Jones, Wendell ; Homan, Wayne F. ; Cummings, Doyle M. ; Cené, Crystal W. ; Hinderliter, Alan L. ; Miller, Cassandra L. ; Donahue, Katrina E. ; Garcia, Beverly A. ; Keyserling, Thomas C. ; Ammerman, Alice S. ; Patterson, Cam ; Dewalt, Darren A. ; Johnston, Larry F. ; Willis, Monte ; Schisler, Jonathan C. / Applicability of precision medicine approaches to managing hypertension in rural populations. In: Journal of Personalized Medicine. 2018 ; Vol. 8, No. 2.
@article{061f7e1e18334375a94f8ff5a5bf1561,
title = "Applicability of precision medicine approaches to managing hypertension in rural populations",
abstract = "As part of the Heart Healthy Lenoir Project, we developed a practice level intervention to improve blood pressure control. The goal of this study was: (i) to determine if single nucleotide polymorphisms (SNPs) that associate with blood pressure variation, identified in large studies, are applicable to blood pressure control in subjects from a rural population; (ii) to measure the association of these SNPs with subjects’ responsiveness to the hypertension intervention; and (iii) to identify other SNPs that may help understand patient-specific responses to an intervention. We used a combination of candidate SNPs and genome-wide analyses to test associations with either baseline systolic blood pressure (SBP) or change in systolic blood pressure one year after the intervention in two genetically defined ancestral groups: African Americans (AA) and Caucasian Americans (CAU). Of the 48 candidate SNPs, 13 SNPs associated with baseline SBP in our study; however, one candidate SNP, rs592582, also associated with a change in SBP after one year. Using our study data, we identified 4 and 15 additional loci that associated with a change in SBP in the AA and CAU groups, respectively. Our analysis of gene-age interactions identified genotypes associated with SBP improvement within different age groups of our populations. Moreover, our integrative analysis identified AQP4-AS1 and PADI2 as genes whose expression levels may contribute to the pleiotropy of complex traits involved in cardiovascular health and blood pressure regulation in response to an intervention targeting hypertension. In conclusion, the identification of SNPs associated with the success of a hypertension treatment intervention suggests that genetic factors in combination with age may contribute to an individual’s success in lowering SBP. If these findings prove to be applicable to other populations, the use of this genetic variation in making patient-specific interventions may help providers with making decisions to improve patient outcomes. Further investigation is required to determine the role of this genetic variance with respect to the management of hypertension such that more precise treatment recommendations may be made in the future as part of personalized medicine.",
keywords = "GWAS, Hypertension, Precision medicine, Rural population, SNP-age interaction",
author = "Halladay, {Jacqueline R.} and Lenhart, {Kaitlin C.} and Kimberly Robasky and Wendell Jones and Homan, {Wayne F.} and Cummings, {Doyle M.} and Cen{\'e}, {Crystal W.} and Hinderliter, {Alan L.} and Miller, {Cassandra L.} and Donahue, {Katrina E.} and Garcia, {Beverly A.} and Keyserling, {Thomas C.} and Ammerman, {Alice S.} and Cam Patterson and Dewalt, {Darren A.} and Johnston, {Larry F.} and Monte Willis and Schisler, {Jonathan C.}",
year = "2018",
month = "6",
day = "1",
doi = "10.3390/jpm8020016",
language = "English (US)",
volume = "8",
journal = "Journal of Personalized Medicine",
issn = "2075-4426",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "2",

}

TY - JOUR

T1 - Applicability of precision medicine approaches to managing hypertension in rural populations

AU - Halladay, Jacqueline R.

AU - Lenhart, Kaitlin C.

AU - Robasky, Kimberly

AU - Jones, Wendell

AU - Homan, Wayne F.

AU - Cummings, Doyle M.

AU - Cené, Crystal W.

AU - Hinderliter, Alan L.

AU - Miller, Cassandra L.

AU - Donahue, Katrina E.

AU - Garcia, Beverly A.

AU - Keyserling, Thomas C.

AU - Ammerman, Alice S.

AU - Patterson, Cam

AU - Dewalt, Darren A.

AU - Johnston, Larry F.

AU - Willis, Monte

AU - Schisler, Jonathan C.

PY - 2018/6/1

Y1 - 2018/6/1

N2 - As part of the Heart Healthy Lenoir Project, we developed a practice level intervention to improve blood pressure control. The goal of this study was: (i) to determine if single nucleotide polymorphisms (SNPs) that associate with blood pressure variation, identified in large studies, are applicable to blood pressure control in subjects from a rural population; (ii) to measure the association of these SNPs with subjects’ responsiveness to the hypertension intervention; and (iii) to identify other SNPs that may help understand patient-specific responses to an intervention. We used a combination of candidate SNPs and genome-wide analyses to test associations with either baseline systolic blood pressure (SBP) or change in systolic blood pressure one year after the intervention in two genetically defined ancestral groups: African Americans (AA) and Caucasian Americans (CAU). Of the 48 candidate SNPs, 13 SNPs associated with baseline SBP in our study; however, one candidate SNP, rs592582, also associated with a change in SBP after one year. Using our study data, we identified 4 and 15 additional loci that associated with a change in SBP in the AA and CAU groups, respectively. Our analysis of gene-age interactions identified genotypes associated with SBP improvement within different age groups of our populations. Moreover, our integrative analysis identified AQP4-AS1 and PADI2 as genes whose expression levels may contribute to the pleiotropy of complex traits involved in cardiovascular health and blood pressure regulation in response to an intervention targeting hypertension. In conclusion, the identification of SNPs associated with the success of a hypertension treatment intervention suggests that genetic factors in combination with age may contribute to an individual’s success in lowering SBP. If these findings prove to be applicable to other populations, the use of this genetic variation in making patient-specific interventions may help providers with making decisions to improve patient outcomes. Further investigation is required to determine the role of this genetic variance with respect to the management of hypertension such that more precise treatment recommendations may be made in the future as part of personalized medicine.

AB - As part of the Heart Healthy Lenoir Project, we developed a practice level intervention to improve blood pressure control. The goal of this study was: (i) to determine if single nucleotide polymorphisms (SNPs) that associate with blood pressure variation, identified in large studies, are applicable to blood pressure control in subjects from a rural population; (ii) to measure the association of these SNPs with subjects’ responsiveness to the hypertension intervention; and (iii) to identify other SNPs that may help understand patient-specific responses to an intervention. We used a combination of candidate SNPs and genome-wide analyses to test associations with either baseline systolic blood pressure (SBP) or change in systolic blood pressure one year after the intervention in two genetically defined ancestral groups: African Americans (AA) and Caucasian Americans (CAU). Of the 48 candidate SNPs, 13 SNPs associated with baseline SBP in our study; however, one candidate SNP, rs592582, also associated with a change in SBP after one year. Using our study data, we identified 4 and 15 additional loci that associated with a change in SBP in the AA and CAU groups, respectively. Our analysis of gene-age interactions identified genotypes associated with SBP improvement within different age groups of our populations. Moreover, our integrative analysis identified AQP4-AS1 and PADI2 as genes whose expression levels may contribute to the pleiotropy of complex traits involved in cardiovascular health and blood pressure regulation in response to an intervention targeting hypertension. In conclusion, the identification of SNPs associated with the success of a hypertension treatment intervention suggests that genetic factors in combination with age may contribute to an individual’s success in lowering SBP. If these findings prove to be applicable to other populations, the use of this genetic variation in making patient-specific interventions may help providers with making decisions to improve patient outcomes. Further investigation is required to determine the role of this genetic variance with respect to the management of hypertension such that more precise treatment recommendations may be made in the future as part of personalized medicine.

KW - GWAS

KW - Hypertension

KW - Precision medicine

KW - Rural population

KW - SNP-age interaction

UR - http://www.scopus.com/inward/record.url?scp=85047434940&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047434940&partnerID=8YFLogxK

U2 - 10.3390/jpm8020016

DO - 10.3390/jpm8020016

M3 - Article

AN - SCOPUS:85047434940

VL - 8

JO - Journal of Personalized Medicine

JF - Journal of Personalized Medicine

SN - 2075-4426

IS - 2

M1 - 16

ER -